The US Food and Drug Administration has released 2 draft guidance documents for appropriate marketing communication on medical products and devices.
An interview with Penney Cowan, founder and chief executive officer of the American Chronic Pain Association, where she discusses the ACPA's publication aimed at helping healthcare practitioners improve care of patients with chronic pain.
Novel psychosocial therapies such as cognitive behavioral therapy that have been effective in adults with fibromyalgia need additional neuromuscular fitness training to overcome catastrophizing and fear of exercise in adolescents.
End-of-rotation transition in care has been linked to significantly higher in-hospital mortality. Clinicians highlight the issue, and offer ways to reduce the problem.
One researcher shares insight into the prevalence of industry funding of advocacy groups and what clinicians should consider when interpreting research outcomes.
Patient care is more than providing treatment and measuring disease activity, says Jonathan Krant, MD, a rheumatologist from upstate New York. In this interview, the chief of medicine for the Adirondack Health System explains the disconnect between what physicians would like to learn from their patients and what their time constraints allow.
HHS fined providers for not having a business associate agreement in place or using an outdated one.
With billing and reimbursement requirements constantly in flux, clinicians must stay vigilant to ensure continued--and correct--payment.
Machelle Manuel, PhD, vice president of medical scientific affairs, at Ironwood Pharmaceuticals discusses new hyperuricemia treatment options.
Case Studies and Clinical Highlights
A female patient with systemic lupus erythematosus presents to the emergency department with an 8 week history of dyspnea, dysphonia, and non-productive cough.
AA amyloidosis is a rare but significant complication of ankylosing spondylitis (AS) and may lead to proteinuria and renal dysfunction.
Since certain syndromes are associated with good prognosis in a majority of patients with systemic lupus erythematosus, prompt diagnosis and initiation of early goal-directed treatment is crucial.
Rheumatology Advisor Articles
- FDA Developing Guidance on Medical Product Marketing
- Drug-Induced Lupus Observed With Adalimumab Treatment For Psoriasis
- Efficacy of JAK Monotherapy vs Combination Therapy in RA
- Juvenile Arthritis with Sleep Apnea Impairs Neurobehavioral Performance
- FDA Approves Brodalumab Injection for Plaque Psoriasis Treatment